- Home
- KLXE vs TIL Comparison
KLXE vs TIL Comparison
Compare KLXE & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- TIL
- Stock Information
- Founded
- KLXE 2018
- TIL 2018
- Country
- KLXE United States
- TIL United States
- Employees
- KLXE N/A
- TIL N/A
- Industry
- KLXE Oilfield Services/Equipment
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- TIL Health Care
- Exchange
- KLXE Nasdaq
- TIL Nasdaq
- Market Cap
- KLXE 35.8M
- TIL 230.1M
- IPO Year
- KLXE N/A
- TIL 2021
- Fundamental
- Price
- KLXE $1.95
- TIL $28.50
- Analyst Decision
- KLXE Hold
- TIL Buy
- Analyst Count
- KLXE 1
- TIL 5
- Target Price
- KLXE $4.50
- TIL $119.00
- AVG Volume (30 Days)
- KLXE 295.3K
- TIL 349.6K
- Earning Date
- KLXE 08-06-2025
- TIL 08-12-2025
- Dividend Yield
- KLXE N/A
- TIL N/A
- EPS Growth
- KLXE N/A
- TIL N/A
- EPS
- KLXE N/A
- TIL N/A
- Revenue
- KLXE $688,600,000.00
- TIL N/A
- Revenue This Year
- KLXE N/A
- TIL N/A
- Revenue Next Year
- KLXE $3.97
- TIL N/A
- P/E Ratio
- KLXE N/A
- TIL N/A
- Revenue Growth
- KLXE N/A
- TIL N/A
- 52 Week Low
- KLXE $1.51
- TIL $9.62
- 52 Week High
- KLXE $7.66
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- KLXE 45.50
- TIL 52.42
- Support Level
- KLXE $1.84
- TIL $20.60
- Resistance Level
- KLXE $2.06
- TIL $31.67
- Average True Range (ATR)
- KLXE 0.29
- TIL 3.88
- MACD
- KLXE -0.04
- TIL -1.08
- Stochastic Oscillator
- KLXE 9.48
- TIL 42.47
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.